Hereditary deficiency of the 79 amino acid SP-B peptide in human infants and SP-B knockout mice invariably results in neonatal respiratory distress syndrome and death. Although the mature airway form of SP-B is a sulfhydryl-dependent dimer (Mr approx. 18 kD), the role of dimer formation in SP-B function is unknown. The current study was undertaken to test the hypothesis that dimerization of SP-B is essential for proper function, structure, and metabolism of pulmonary surfactant. To test this hypothesis, a dimerization deficient human SP-B construct was generated by mutation of the cysteine that is purported to be critical for dimer formation (cys48 --> ser). The sequence encoding mutated SP-B preproprotein was subsequently cloned under the control of the 3.7 kB human SP-C promoter, which directs expression to type II and Clara cells, and injected into fertilized FVB/N eggs. Three transgenic lines were established and characterized. Monomeric, mature human SP-B peptide was detected in lung homogenates from transgene positive animals following SDS-PAGE under non-reducing conditions. The level of transgene expression was comparable to endogenous murine SP-B peptide levels in all three transgenic lines and resulted in no overt pathophysiology; further, human SP-B monomers were detected in alveolar lavage fluid of transgene positive animals, indicating that the monomeric form was secreted. We conclude that dimerization of SP-B is not essential for correct targeting of SP-B to the lamellar body or for proteolytic processing of the SP-B proprotein to the mature peptide. These results suggest that dimer formation is not critical for intracellular trafficking of SP-B. In order to test the hypothesis that dimerization is essential for the extracellular function of SP-B, dimerization deficient transgenic mice are currently being crossed with hemizygous mice(SP-B +/-) in order to achieve expression of human monomeric SP-B in SP-B knockout mice. These mice will be assessed to determine if monomeric SP-B can rescue the lethal SP-B(-/-) phenotype and to evaluate the effect of monomeric SP-B expression on lung compliance, alveolar epithelial cell ultrastructure, and surfactant phospholipid composition. (Supported by NIH HL56285 to TEW).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beck, D., Weaver, T. Role of Pulmonary Surfactant Protein B (SP-B) Dimerization •228. Pediatr Res 41 (Suppl 4), 40 (1997). https://doi.org/10.1203/00006450-199704001-00248
Issue Date:
DOI: https://doi.org/10.1203/00006450-199704001-00248